Universal Health Services, Inc. UHS

NYSE · Healthcare · Medical - Care Facilities

$179.43

Close on Fri, 20 Nov 2026 · market value $9B

What the price is betting on

Below its record

At $179, the price assumes revenue shrinks about 8.8% a year for five years, from $18.4B to about $12.4B by FY2030. That is less than what analysts expect for the next two years and less than the company's own last three years.

The price assumes−8.8%
Analysts, next two years4.7%
Last 3 years9.6%

Revenue growth a year. The price figure comes from a reverse DCF at a 9.4% discount rate.

Track it and Parra checks each report against the path, and tells you when revenue falls behind it.

Own more than UHS? Check up to 5 of your stocks at once, free, no account.

0$10B$20B$30B$18.4B'22'23'24'25Sep '26'26'27'28'29'30What the price needsReportedAnalysts

Both sides

Three stories, three values

Bear

$210

Base

$348

Bull

$434

Today $179

  • Bear $210. Capital spending keeps climbing and free cash flow slides back below the weaker FY2025 level. Coverage losses, Medicaid cuts and steeper payment contractions from 2028 hit revenue for several years, and thin cash with moderate debt leaves little room, so the low multiple is a fair price for a shrinking cash stream.
  • Base $348. Free cash flow stays near the level of the last twelve months, but capital spending stays high and the 2027-2028 Medicaid and coverage-loss pressure holds cash flow growth a little below what analysts expect. Steady admissions and acute care growth offset most of the payer squeeze, without much leverage left over.
  • Bull $434. Capital spending levels off, so free cash flow holds near its recent level. Admissions keep growing, acute care keeps outgrowing behavioral health, and the heavy cost base spreads over a bigger revenue line, so the payer squeeze stays close to the loss management has projected and cash flow beats expectations.

AI-written stories, valued by code from the same model.

Checkpoints

The revenue the price needs

  1. YearNeedsAnalysts expect
  2. FY2026$17.9B$18.6B, on the path
  3. FY2027$16.4B$19.5B, on the path
  4. FY2028$14.9B$20.3B, on the path
  5. FY2029$13.6B$21.2B, on the path
  6. FY2030$12.4B$22.1B, on the path

Each year's revenue at −8.8% growth from $18.4B in the 12 months to September 2026.

At a glance

Healthcare · Medical - Care Facilities · listed on NYSE

Revenue, FY2025
$17.4B
Growth, 3 years a year
9.6%
Cash margin
4.9%
Net debt
$5.4B
Shares, 3-year change
−13%
Dividend yield
0.6%

What other healthcare prices are betting on

Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.